Injective (INJ) is gaining market attention after Canary Capital’s Staked INJ ETF secured Nasdaq listing approval, marking another milestone in the network’s expansion into traditional financial markets. The development could improve institutional access to INJ through an investment product offering staking exposure. Meanwhile, the INJ price has regained bullish momentum after breaking above $7.30. Crypto analyst Trader Symba sees further upside potential, identifying $7.55 and the $8.00–$8.20 range as important targets.
Table of Contents
Canary’s Staked INJ ETF Moves Closer to Nasdaq Trading
Injective’s institutional adoption has reached another milestone after Canary Capital’s Staked INJ ETF secured Nasdaq listing approval. The development is highlighted by Eagle.inj, which described the approval as recognition of years of development, innovation, and ecosystem expansion.
The ETF is designed to provide investors with exposure to INJ while incorporating staking activities. This structure could allow shareholders to access potential staking rewards without directly managing tokens or operating staking infrastructure.
Source: Eagle.inj’s X Post
The development is significant because exchange-traded products can make cryptocurrency exposure more accessible to investors who prefer traditional brokerage accounts. However, listing approval should not be confused with the actual start of trading. Its launch and subsequent investor participation will remain important developments to monitor.
Also Read: INJ Price in Focus as Injective Advances Toward Staked ETF Milestone
INJ Gains Market Attention Following ETF Approval
The ETF development provides a fresh institutional narrative for Injective as its native token attempts to strengthen its market structure. Combining traditional investment access with staking exposure could attract investors seeking alternatives to directly holding digital assets.
Meanwhile, INJ’s price recovery has added another dimension to the market narrative. The token was recently reported trading around $7.64, gaining approximately 9% over 24 hours. This recovery placed INJ above the $7.30 breakout level highlighted by Trader Symba.
Sustained buying activity will be important to determine whether the recovery can develop into a broader upward trend. Investors will also monitor the ETF’s eventual launch and capital flows for signs of growing institutional interest.
INJ Price Breaks $7.30 as Bullish Momentum Builds
According to crypto analyst Trader Symba, the INJ price has broken out of a wedge formation and completed a successful retest of the breakout area. The analyst identified $7.30 as an important resistance level that buyers managed to overcome, opening the possibility of further upside.
Trader Symba initially identified $7.55 as the next target, followed by a potential extension toward $8.00–$8.20. Subsequent market data showing the INJ price around $7.64 indicates that the initial target has already been exceeded.
Source: Trader Symba’s X Post
However, the broader technical picture still requires confirmation. INJ was trading above its seven-day moving average but below its 20-day moving average near $7.92. Its Relative Strength Index (RSI) stood around 50, suggesting relatively neutral momentum.
A sustained move above $7.92 could strengthen the recovery and bring the $8.00–$8.20 range into focus. Conversely, losing the $7.30 breakout area could weaken the bullish setup and increase the possibility of further consolidation.
Trader Symba Identifies $8.20 as the Next Target
Trader Symba sees improving conditions for Injective following its wedge breakout and successful retest. The analyst’s assessment suggests that reclaiming $7.30 has strengthened the short-term structure and created room for another upward move.
Although the initial $7.55 target has been exceeded, the higher $8.00–$8.20 range remains relevant. However, reaching these levels will depend on sustained buying pressure and INJ maintaining its breakout structure. These projections remain conditional rather than guaranteed outcomes.
What Comes Next for INJ?
The next major development to watch is the Canary Staked INJ ETF’s progression toward actual trading. Its eventual launch and initial fund flows will provide a clearer picture of institutional demand and investor interest in Injective.
On the technical side, $7.30 remains an important support reference following the reported breakout. A sustained recovery above $7.92 could improve the short-term outlook, while a move toward $8.00–$8.20 would bring Trader Symba’s higher targets into focus.
Injective’s Nasdaq listing approval marks an important institutional milestone, while INJ’s recovery above $7.30 adds a bullish technical dimension. The ETF’s trading launch and the token’s ability to maintain its breakout structure will be key factors in determining whether the recovery can extend further.
Also Read: Injective Stockdrop is Set to Launch as INJ Price Eyes a Potential Breakout
This article contains market analysis and price predictions. These are not guarantees. Crypto markets are volatile. Always DYOR. Not financial advice.
Mishal Ali is a Policy and Regulations Reporter at Tron Weekly with over four years of experience covering the global crypto and blockchain space. Her reporting focuses on crypto regulations and policy, alongside Bitcoin, Ethereum, altcoins, DeFi, NFTs, Web3, Layer 2 solutions, and AI-driven crypto use cases. She also tracks Ripple-related developments, enforcement actions, licensing updates, and crypto scams and fraud trends, helping readers understand regulatory and compliance risks.
